About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Pennsylvania | 30,737 Studies Near You

Clinical TrialsPennsylvania

Clinical Trials in Pennsylvania

Discover 30,737 clinical trials near Pennsylvania. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2501-2520 of 30,737 trials

CompletedRandomized On-X Anticoagulation TrialVarious patient groups with the On-X Valve can be maintained safely on lower doses of blood thinner(Coumadin®) or on antiplatelet drugs (aspirin/Plavix®) only rather than the…NCT00291525·Tucson, Arizona and 48 others

Find Trials by Condition in Pennsylvania

Breast Cancerin Pennsylvania Lung Cancerin Pennsylvania Prostate Cancerin Pennsylvania Colorectal Cancerin Pennsylvania Melanomain Pennsylvania Leukemiain Pennsylvania Lymphomain Pennsylvania Pancreatic Cancerin Pennsylvania Ovarian Cancerin Pennsylvania Brain Cancerin Pennsylvania

Data from ClinicalTrials.govTerms

TerminatedQuinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal AdenocarcinomaEstablish the tolerability and safety of aimed dose of both quinacrine and capecitabine in combination to treat patients with advanced colorectal adenocarcinoma.NCT01844076·Philadelphia, Pennsylvania

CompletedTopical Lidocaine Patch in Low Back PainPatients with acute or chronic Lower Back Pain (LBP) participated in a Phase IV clinical trial to assess the effectiveness of Lidoderm administered once daily (q24h) for 2 weeks…NCT00904540·Phoenix, Arizona and 6 others

TerminatedBempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid TumorsThis study is to assess the safety and tolerability, and to assess the preliminary clinical benefit of NKTR-214 when combined with pembrolizumab (KEYTRUDA®) with or without…NCT03138889·Fayetteville, Arkansas and 37 others

CompletedStudy to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic DermatitisThis is an open-label, single arm study of 52 weeks duration.NCT04250350·Anniston, Alabama and 69 others

RecruitingA Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 DiabetesThis multi-center randomized controlled trial will assess the safety and efficacy of ATG followed by either adalimumab or verapamil in preserving insulin secretion 2 years from…NCT07061574·San Francisco, California and 9 others

Active not recruitingMigraine and CVD Risk in WomenThe primary goal of this study is to test the effects of a high-fat, high-carbohydrate mixed meal on candidate modulators of cardiovascular disease risk (inflammation, vascular…NCT03081390·Philadelphia, Pennsylvania and 1 other

CompletedSynchronized Brain and Hand Stimulation After StrokeAmong the 795,000 individuals who sustain a stroke annually in the United States, 65% continue to experience moderate-to-severe impairments in one hand six months or more, which…NCT04502290·Pittsburgh, Pennsylvania

CompletedSafety, Tolerability, and Antiviral Activity of ANA598 Administered in Combination With Pegylated Interferon and Ribavirin for the Treatment of Genotype-1 Chronic HCV InfectionThe purpose of this study is to assess the safety, tolerability and effectiveness of ANA598 when administered with pegylated interferon and ribavirin (Standard of Care \[SOC\])…NCT00978497·Anaheim, California and 20 others

CompletedAnalysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD SubjectsA Phase 2/3 cross-sectional and longitudinal observational study evaluating imaging characteristics of flortaucipir in control subjects and patients with clinically defined MCI…NCT02016560·Phoenix, Arizona and 26 others

RecruitingIntraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDHThis study evaluates the feasibility and utility of contrast-enhanced ultrasound to provide real-time assessment of blood flow to the femoral head in infants undergoing surgical…NCT03107520·Philadelphia, Pennsylvania

RecruitingA Study to Evaluate Avacopan in Participants With ANCA-associated VasculitisThe primary objective of this study is to evaluate the long-term safety of avacopan in participants with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).NCT06072482·Anchorage, Alaska and 82 others

CompletedEffect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 DiabetesThis trial is conducted in Europe and the United States of America (USA).NCT00518882·Birmingham, Alabama and 124 others

CompletedStudy of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary FibrosisStudy RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.NCT04708782·Birmingham, Alabama and 97 others

TerminatedEffect of Concentrating Endogenous Stromal Cells in the Fat GraftTraumatic facial injuries, especially those sustained in military combat, are characterized by destruction of bone and soft tissue.NCT01564524·Pittsburgh, Pennsylvania

RecruitingA Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic MalignanciesThe TEMPUS AQUARIUS Study is a non-interventional, longitudinal observational study focused on hematological malignancies.NCT07154823·Iowa City, Iowa and 9 others

Completed24-week Study With Open Label Extension of VX-509, an Oral JAK3 Inhibitor, in Subjects Taking MethotrexateThis study is designed to evaluate the safety and efficacy of VX-509, an oral JAK3 inhibitor, for treatment of subjects with active RA who have had an inadequate response to…NCT01590459·Birmingham, Alabama and 93 others

CompletedStudy Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or LymphomaTo compare the safety and efficacy of piperacillin/tazobactam (4 g/500 mg) administered intravenously every 6 hours to cefepime (2 g) administered intravenously every 8 hours for…NCT00044759·Little Rock, Arkansas and 35 others

Active not recruitingA Study of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DMEEYE-RES-103 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of EYE103 in comparison with the active control, ranibizumab, in…NCT06957080·Gilbert, Arizona and 163 others

CompletedC-Pulse IDE Feasibility Study- A Heart Assist SystemThe C-Pulse Feasibility Study is evaluating the safety and performance of a new product for the treatment of heart failure.NCT00815880·Birmingham, Alabama and 5 others

PreviousPage 126 of 1537Next

Diabetes

in Pennsylvania

Heart Diseasein Pennsylvania